dc.contributor.author | Chege, Evelynn N | |
dc.date.accessioned | 2017-12-18T07:47:19Z | |
dc.date.available | 2017-12-18T07:47:19Z | |
dc.date.issued | 2017 | |
dc.identifier.uri | http://hdl.handle.net/11295/101987 | |
dc.description.abstract | Cancer is a growing disease burden in our country.Contributing to it are central nervous tumours and most commonly glial tumours which are intracranial.knowing the type of tumour the patient suffers from dictates treatment options and the patient's pronosis.The most common malignant glial tumour is glial is glioblastoma which may be primary or IDHI mutatin glioblastoma (secondary.) | |
dc.language.iso | en | en_US |
dc.publisher | University of Nairobi | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.subject | Role of Immunohistochemistry | en_US |
dc.title | Role of Immunohistochemistry in the Diagnosis of Glioblastoma and Anaplastic Astrocytoma at Kenyatta National Hospital | en_US |
dc.type | Thesis | en_US |
dc.description.department | a
Department of Psychiatry, University of Nairobi, ; bDepartment of Mental Health, School of Medicine,
Moi University, Eldoret, Kenya | |